AU2003286692A1 - Modulation of dendritic cell function and other cellular responses mediated by defensin compositions - Google Patents
Modulation of dendritic cell function and other cellular responses mediated by defensin compositionsInfo
- Publication number
- AU2003286692A1 AU2003286692A1 AU2003286692A AU2003286692A AU2003286692A1 AU 2003286692 A1 AU2003286692 A1 AU 2003286692A1 AU 2003286692 A AU2003286692 A AU 2003286692A AU 2003286692 A AU2003286692 A AU 2003286692A AU 2003286692 A1 AU2003286692 A1 AU 2003286692A1
- Authority
- AU
- Australia
- Prior art keywords
- defensin
- modulation
- compositions
- dendritic cell
- cell function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42148802P | 2002-10-25 | 2002-10-25 | |
US60/421,488 | 2002-10-25 | ||
PCT/US2003/033940 WO2004038002A2 (en) | 2002-10-25 | 2003-10-24 | Modulation of dendritic cell function and other cellular responses mediated by defensin compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003286692A8 AU2003286692A8 (en) | 2004-05-13 |
AU2003286692A1 true AU2003286692A1 (en) | 2004-05-13 |
Family
ID=32176721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003286692A Abandoned AU2003286692A1 (en) | 2002-10-25 | 2003-10-24 | Modulation of dendritic cell function and other cellular responses mediated by defensin compositions |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003286692A1 (en) |
WO (1) | WO2004038002A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080286312A1 (en) * | 2002-06-12 | 2008-11-20 | Gavish-Galilee Bio Applications Ltd. | Membrane-anchored beta2 microglobulincovalently linked to MHC class I peptide epitopes |
MA44334A (en) | 2015-10-29 | 2018-09-05 | Novartis Ag | ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST |
-
2003
- 2003-10-24 AU AU2003286692A patent/AU2003286692A1/en not_active Abandoned
- 2003-10-24 WO PCT/US2003/033940 patent/WO2004038002A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003286692A8 (en) | 2004-05-13 |
WO2004038002A3 (en) | 2005-01-27 |
WO2004038002A2 (en) | 2004-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003253897A1 (en) | Dendritic cell pontentiation | |
AU2002318944A1 (en) | Methods and compositions relating to plasmacytoid dendritic cells | |
AU2003259735A1 (en) | Small-mer compositions and methods of use | |
AU2003225530A1 (en) | Solid polymer electrolyte and method of preparation | |
AU2003244417A1 (en) | Cellular mosfet devices and their manufacture | |
EP2295041A3 (en) | HRT formulations | |
AU2003249284A1 (en) | Modulators of cellular proliferation | |
AU2003207798A1 (en) | Degradable crosslinkers, and degradable crosslinked hydrogels comprising them | |
AU2003299441A1 (en) | Nf-hev compositions and methods of use | |
AU2003228205A1 (en) | Porous polymers: compositions and uses thereof | |
AU2003210899A1 (en) | Adhesive compositions and tapes comprising same | |
AU2003247351A1 (en) | Anti-acne compositions and methods of use | |
AU2003213120A1 (en) | Human rnase iii and compositions and uses thereof | |
AU2003216840A1 (en) | Transdifferentiation of cells and tissues | |
AU2003239579A1 (en) | Antisense modulation of vegf-c expression | |
AU2003240281A1 (en) | Cell targeting methods and compositions | |
AU2003286692A1 (en) | Modulation of dendritic cell function and other cellular responses mediated by defensin compositions | |
AU2002316552A1 (en) | Inhibitor of t cell activation | |
AU2003287188A1 (en) | Activation of hcv-specific cells | |
AU2003286312A1 (en) | Method and mobile terminal arrangement for fast switching between multiple peripherals | |
AU2003268078A1 (en) | Levothyroxine compositions and methods | |
AU2003253780A1 (en) | TCELL TOLERANCE AND MODULATION OF AUTOIMMUNITY BY CD8Alpha-CD4+ DENDRITIC CELLS | |
AU2003901205A0 (en) | Therapeutic and prophylactic compositions and uses therefor | |
AU2002357726A1 (en) | Compositions and methods for the suppression of mammary epithelial cell proliferation | |
AU2003291015A1 (en) | Compositions containing an active fraction isolated from tannins and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |